Skip to main content
Clinical Trials/NCT06510192
NCT06510192Not yet recruitingNot Applicable

Yuva Sath: A Peer-led Behavioral Intervention to Support Substance Use Treatment and HIV Prevention Among Young People Who Inject Drugs in India

Massachusetts General Hospital0 sites60 target enrollmentStarted: January 1, 2027Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
60
Primary Endpoint
Feasibility of the Yuva Sath Intervention: Peer counselor fidelity

Study Overview

Brief Summary

The goal of this pilot randomized controlled trial is to learn if Yuva Sath, a youth-tailored peer-led behavioral intervention, can support substance use treatment engagement and HIV prevention among young people who inject drugs in India. The main questions it aims to answer are:

  • Is Yuva Sath feasible and is it acceptable to young people who inject drugs in India ?
  • Can Yuva Sath improve engagement in substance use treatment, increase use of HIV prevention services and decrease substance use and risk behaviors among young people who inject drugs in India ?

Researchers will compare participants who receive the Yuva Sath behavioral intervention to participants who do not to see if the behavioral intervention improves substance use treatment engagement and HIV prevention.

Participants will:

  • Receive a total of 6 one-on-one sessions, and weekly phone text check-ins from peer counselors over a course of 6 months.
  • Complete monthly random urine drug screens
  • Complete in-person study questionnaires every 3 months
  • Report substance use and risk behaviors weekly to peer counselors through a brief phone text message survey

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 29 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age 18-29 years;
  • Receiving medications for opioid use disorder (MOUD) for at least 3 months and receipt frequency < 2 times a week

Exclusion Criteria

  • Receiving medications for opioid use disorder (MOUD) for less than 3 months and receipt frequency >= 2 times a week
  • Requiring urgent medical attention
  • Inability to provide informed consent

Outcomes

Primary Outcomes

Feasibility of the Yuva Sath Intervention: Peer counselor fidelity

Time Frame: 6 months.

Feasibility of the Yuva Sath intervention as measured by peer counselor fidelity to the intervention protocol will be determined by independent observer fidelity checklists. The checklist will score content delivery on a 3-point ordinal scale (1=no key content covered to 3=all key content covered), and peer-navigator actions (i.e., identification of barriers; generation of solutions) on a 5-point Likert scale (1=not at all to 5=very much). The intervention will be deemed to be feasible if 80% of the sessions addressed key Life-Steps module content and employed flexible problem-solving

Feasibility of the Yuva Sath Intervention: Attendance in the first four sessions

Time Frame: 6 months

Feasibility of the Yuva Sath intervention as measured by attendance in the first four sessions will be calculated as a proportion: participants who completed the first four sessions of the total 6 sessions of the intervention/ All participants in the intervention arm. The intervention will be deemed to be feasible if at least 75% of participants completed the first four sessions

Feasibility of the Yuva Sath Intervention: Completion of the 3 month assessment

Time Frame: 3 months

Feasibility of the Yuva Sath intervention as measured by completion of the 3 month session will be calculated as a proportion: participants who completed the 3 month assessment / All participants in the intervention arm. The intervention will be deemed feasible if at least 60% of participants completed the 3-month assessment

Acceptability of the Yuva Sath Intervention

Time Frame: 6 months

Acceptability of the intervention as measured by the overall satisfaction of participants rated on a 5-point Likert scale (1=not at all to 5=very much). The intervention will be deemed acceptable if at least 75% of the participants rate \>=4 on overall satisfaction

Secondary Outcomes

  • Substance use: monthly random point-of-care urinalysis(6 months)
  • Needle sharing: Self report at 3-month assessment(3 months)
  • Substance use: Self report at 3-month assessment(3 months)
  • Needle sharing: self report at 6-month assessment(6 months)
  • Substance use: Self report at 6-month assessment(6 months)
  • Condomless sex: self report at 3-month assessment.(3 months)
  • Substance use treatment engagement: the number of MOUD visits each month(6 months)
  • Substance use treatment engagement: the number of weeks of MOUD receipt at >2 times a week(6 months)
  • Substance use treatment engagement: retention in MOUD at 6 months(6 months)
  • HIV testing receipt(6 months)
  • Condomless sex: self report at 6-month assessment.(6 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Lakshmi Ganapathi

Physician-Investigator

Massachusetts General Hospital

Similar Trials